๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Histopathologic analysis of transjugular intrahepatic portosystemic shunts

โœ Scribed by H Ducoin; J El-Khoury; H Rousseau; K Barange; J Peron; M Pierragi; J Rumeau; J Pascal; J Vinel; F Joffre


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
807 KB
Volume
25
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

โœฆ Synopsis


This prospective study was undertaken in 17 patients treated with 22 transjugular intrahepatic portosystemic shunt (TIPS) procedures and aimed to evaluate the nature and causes of short- and long-term shunt abnormalities. Specimens were collected after autopsy in 6 patients and after liver transplantation in 11 patients; the time from shunting ranging from 4 to 385 days. During the first 2 weeks the shunt surface was covered by poorly organized fibrin platelet clots that were mixed with inflammatory and red blood cells. Thereafter, a pseudointima developed, initially made of loose granulation tissue that was formed by edema, myofibroblasts, neo-capillaries, collagen fibers, and inflammatory cells. This pseudo-intima extended with time as the myofibroblasts increased in number, as the collagen fibers thickened, and as the inflammatory cells grew more scarce. Its thickness ranged from 50 to 3,500 microm, the maximal values being observed in the middle of the shunt. The shunt was obstructed by a clot in 4 patients (18%). In 7 shunts (31.8%) the pseudo-intima was thicker than 1,000 microm and was referred to as hyperplastic pseudo-intima. It showed more dense inflammatory infiltrate and anarchic deposition of more scarce collagen fibers. Pseudo-intima hyperplasia was associated with previously diagnosed thrombosis, which had been treated by dilatation in 2 cases and by biliary deposits in 3 cases, while it remained unexplained in 2 cases. Accordingly, this study confirms the following: 1) that early TIPS obstruction results from thrombosis; 2) that 2 weeks after insertion, the stent is covered by a smooth pseudo-intima; 3) that thereafter, pseudo-intimal hyperplasia is the main cause of TIPS stenosis or occlusion; and 4) that biliary secretions and previous thrombosis could be important triggering mechanisms for this pseudo-intima overgrowth.


๐Ÿ“œ SIMILAR VOLUMES


Transjugular intrahepatic portosystemic
โœ Jorge Ortiz; Eyob Feyssa; Victor Araya; Stalin Campos ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 37 KB

A Case-Controlled Study of the Safety and Efficacy of Transjugular Intrahepatic Portosystemic Shunts After Liver Transplantation.'' 1 We published the outcomes for 26 patients who underwent transjugular intrahepatic portosystemic shunt (TIPS) placement for intractable ascites after liver transplanta

Transjugular intrahepatic portosystemic
โœ Millis, J. Michael ;Martin, Paul ;Gomes, Antoinette ;Shaked, Abraham ;Colquhoun, ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 732 KB

This study was designed to evaluate the impact of transjugular intrahepatic portosystemic shunts (TIPS) on liver transplantation. Historically, the complications of portal hypertension have been temporized with sclerotherapy or surgical portosystemic shunts. In patients whose liver disease progresse

The hematologic consequences of transjug
โœ A J Sanyal; A M Freedman; P P Purdum; M L Shiffman; V A Luketic ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 340 KB

jects. However, it is self-limited and rarely requires SEE EDITORIAL ON PAGE 177. intervention. Potential mechanisms of such hemolysis are discussed. TIPS is also not recommended as a means of improving platelet counts in patients with Transjugular intrahepatic portosystemic shunts (TIPS) severe hyp

Use of transjugular intrahepatic portosy
โœ James D. Perkins ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 87 KB

Background: Transjugular intrahepatic portosystemic shunts (TIPS) have been used to control symptomatic portal hypertension in patients awaiting liver transplant. Although their role in pretransplantation patients is well established, their role in posttransplantation patients is unclear. Study Desi

Transjugular intrahepatic portosystemic
โœ Michael J. Wallace; David C. Madoff; Kamran Ahrar; Carla L. Warneke ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 101 KB

## BACKGROUND. Transjugular intrahepatic portosystemic shunt (TIPS) placement has emerged as an effective and minimally invasive method of treating portal hypertension and its associated complications. To the authors' knowledge there is limited documentation of its use for percutaneous shunting in